Blue light from electronic devices may be an important factor for vitreous floaters

Chen, Jintao; Wu, Haibing

doi:10.1016/j.mehy.2020.109698

Cited by 2 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the daytime, we need a certain brightness to capture the information on a screen, but high-energy blue rays emitted by electronic products will again inevitably lead to eye damage. Blue ray is located at 400–500 nm, a short wavelength with high energy and strong penetrating power. , But the lowest wavelength emitted is 430 nm for electronic products, so the isolation of the high-energy blue ray region (430–500 nm) is the focus of eye protection. In this work, we devoted ourselves to developing available electrochromic eye-protection filters with “day mode” and “night mode” to minimize the harmful effects of light on the eyes.…”

Section: Resultsmentioning

confidence: 99%

Dual Polymer Complementarity Induced Truly Black Electrochromic Film and the Construction of Intelligent Eye-Protection Filters

Li,

Cui,

et al. 2023

ACS Appl. Mater. Interfaces

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Dual Polymer Complementarity Induced Truly Black Electrochromic Film and the Construction of Intelligent Eye-Protection Filters

Li,

Cui,

et al. 2023

ACS Appl. Mater. Interfaces

View full text Add to dashboard Cite

A New Pharmacological Vitreolysis through the Supplement of Mixed Fruit Enzymes for Patients with Ocular Floaters or Vitreous Hemorrhage-Induced Floaters

Hung

Takeuchi

et al. 2022

JCM

View full text Add to dashboard Cite

Purpose: Ocular floaters caused by vitreous degeneration or blood clots may interfere with various visual functions. Our study investigated the pharmacologic effects of oral supplementation of mixed fruit enzymes (MFEs) for treating spontaneous symptomatic vitreous opacities (SVOs) and those secondary to vitreous hemorrhage (VH). Methods: 224 patients with monocular symptomatic vitreous opacities (SVOs) were recruited between September and December 2017 and received oral supplementation of MFEs (190 mg bromelain, 95 mg papain, and 95 mg ficin) for 3 months in a double-blind clinical trial. Participants were divided according to the etiology of the SVOs, spontaneous (experiment 1) versus VH (experiment 2), and then randomly assigned into four treatments groups: one group received oral vitamin C, as a placebo; and the other 3 groups received 1 capsule per day (low dose), 2 capsules per day (middle dose), or 3 capsules per day (high dose) of MFEs. The number of SVOs was determined at baseline and then 1, 2, and 3 months after initiating treatment. Further, in cases secondary to VH, the changes in corrected distance visual acuity (CDVA) were assessed after 3 months. Second, we compared the free radical scavenging capabilities of each substance: vitamin C, bromelain, papain, ficin, and MFEs (combination of bromelain, papain, and ficin) by DDPH assay. Finally, SVOs-related symptoms and satisfaction with the treatments were evaluated at the last follow-up visit Results: In experiment 1, the disappearance rate of SVOs was 55%, 62.5%, and 70% after taking 1, 2, and 3 capsules daily, respectively (total p < 0.001), in a dose-dependent manner. In experiment 2, the disappearance rate of VH-induced SVOs was 18%, 25%, and 56% (p < 0.001) after 1, 2, and 3 capsules of the supplement daily, respectively. Additionally, the patients’ vision elevated from 0.63LogMAR to 0.19LogMAR (p = 0.008). Conclusions: A pharmacological approach using a high dose of oral supplementation with MFEs (bromelain, papain, and ficin) was effective in reducing vitreous opacities, even after intraocular hemorrhage. Furthermore, pharmacologic vitreolysis with MFEs supplementation showed high patient satisfaction, and also improved CDVA in patients with vitreous hemorrhage-induced floaters

show abstract

Blue light from electronic devices may be an important factor for vitreous floaters

Cited by 2 publications

References 6 publications

Dual Polymer Complementarity Induced Truly Black Electrochromic Film and the Construction of Intelligent Eye-Protection Filters

Dual Polymer Complementarity Induced Truly Black Electrochromic Film and the Construction of Intelligent Eye-Protection Filters

A New Pharmacological Vitreolysis through the Supplement of Mixed Fruit Enzymes for Patients with Ocular Floaters or Vitreous Hemorrhage-Induced Floaters

Contact Info

Product

Resources

About